Clinical Trial Update: PolyTreg Immunotherapy in Islet Transplantation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating PolyTreg Immunotherapy in islet transplantation for Type 1 diabetes mellitus; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• PolyTreg Immunotherapy

Snippet

Sponsor: University of Alberta | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED